Mutant Peptide Lists

Overview

Mutation Count in Gene

Sample Information

Sample Type Cell-Line HLA Types Not Available
Primary Site Bone Site Subtype Pelvis
Primary Histology Ewing_sarcoma-Peripheral_primitive_neuroectodermal_tumour, Ewings_sarcoma-Peripheral_primitive_neuroectodermal_tumour Histology Subtype Ns
Gender Male Age Not Available
Ethnicity Turkish, Caucasian Tumour Source Metastasis, Ascites

Mutation Source

COSMIC Cell line COSMIC tissue CCLE PubMed

Mutation Information

Total Genes Total Mutant Peptides
316 678

Overview

HLA Information

HLA Class I HLA Class II
HLA_A HLA_B HLA_C HLA_DQA1 HLA_DPB1 HLA_DQB1 HLA_DRB1
68:01,01:01 40:01,49:01 07:01,01:02 03:02,03:02 None None 11:01,13:02
RPKM HLA_DQA1 rpkm 0.03 ; HLA_DRB1 rpkm 0.05 ; HLA_C rpkm 67.39 ; HLA_B rpkm 35.76 ; HLA_A rpkm 59.99
Note In HLA_DQA1 03:02 , HLA_DRB1 11:01 and 13:02 , HLA_C 07:01 , HLA_B 40:01. Ambiguity on 4 digit level. Chosen allele had the highest number of reads.

Sample Information

Sample Type Cell-Line HLA Types Not Available
Primary Site Bone Site Subtype Pelvis
Primary Histology Ewing_sarcoma-Peripheral_primitive_neuroectodermal_tumour, Ewings_sarcoma-Peripheral_primitive_neuroectodermal_tumour Histology Subtype Ns
Gender Male Age Not Available
Ethnicity Turkish, Caucasian Tumour Source Metastasis, Ascites
CAN-IMMUNE ID Gene Symbol Transcript Accession Mutation AA Mutation CDS Mutation Type Source Database Mutant Peptide Source Map ID
Settings

Logo Header


Navbar Header


Sidebar

Background